Stay updated on Belantamab Mafodotin in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Mafodotin in Myeloma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Enrollment is no longer open for the study, indicating recruitment has ended. The history now shows a new version label, v3.6.0, replacing the prior v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-13T01:11:26.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The history now includes a new revision entry for v3.5.5, replacing the previous v3.5.4. This represents a software release update to the page history.
    Difference
    0.1%
    Check dated 2026-06-05T22:15:02.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Added a new revision entry 'Revision: v3.5.4' to the study record history and removed the previous 'Revision: v3.5.3' entry. The version history now reflects the latest revision of the record.
    Difference
    0.1%
    Check dated 2026-05-15T15:53:58.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The web interface’s revision version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the underlying ClinicalTrials.gov record details.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:52.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; removed Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:31.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Added a new 'Study Status' entry to the record history and updated the latest version indicator to 10. The 2025-12-15 entry was removed from the history.
    Difference
    0.4%
    Check dated 2026-03-26T11:24:41.000Z thumbnail image

Stay in the know with updates to Belantamab Mafodotin in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.